Gayle Campbell and Professor Pardeep Jhund discuss secondary prevention for heart failure patients, including key topics such as preventing reinfarction, foundational anti-failure agents, managing worsening heart failure, and improving patient adherence using tools like MedTap.
Dr Paul Foley and Prof Terry McCormack share the key changes in the new ESC guidance on atrial fibrillation, hypertension and arterial disease.
AstraZeneca has provided a sponsorship towards this independent programme. AstraZeneca has had no editorial input into or control over the agenda, content development or choice of speakers, nor opportunity to influence except for the AstraZeneca sponsored symposia presentations. The remainder of the programme has remained under the full editorial control of the British Journal of Cardiology.
Dr Sarah Birkhoelzer and Dr Aaron Henry discuss hot topics and late-breaking abstracts from across the congress.
AstraZeneca has provided a sponsorship towards this independent programme. AstraZeneca has had no editorial input into or control over the agenda, content development or choice of speakers, nor opportunity to influence except for the AstraZeneca sponsored symposia presentations. The remainder of the programme has remained under the full editorial control of the British Journal of Cardiology.
Join Professor Chim Lang and Dr Su-Lee Xiao as they discuss the role that digoxin still has to play in heart failure management and what to look out for when treating high-risk patients.
Thanks for your feedback. Please note that by including your email address, you are giving permission for us to contact you by email to help resolve any issues.